John R Moore Edgewise Therapeutics, Inc. (EWTX) insider trading activity

EWTX Quotes by TradingView

John R Moore is General Counsel of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 3,252 shares of EWTX, which is worth approximately $63,186. The most recent transaction as insider was on Jun 16, 2022, when has been sold 14,722 shares (Common Stock) at a price of $6.17 per share, resulting in proceeds of $90,835. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.25K
Infinity% 3M change
50.46% 12M change
Total Value Held $63,186

JOHN R MOORE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2022
SELL
Open market or private sale
$90,835 $6.17 p/Share
14,722 Reduced 83.07%
3,000 Common Stock
Jun 16 2022
BUY
Exercise of conversion of derivative security
$28,413 $1.93 p/Share
14,722 Added 45.38%
17,722 Common Stock
Jun 15 2022
SELL
Open market or private sale
$114,013 $6.11 p/Share
18,660 Reduced 86.15%
3,000 Common Stock
Jun 15 2022
BUY
Exercise of conversion of derivative security
$24,631 $1.32 p/Share
18,660 Added 46.28%
21,660 Common Stock
Jun 14 2022
SELL
Open market or private sale
$21,841 $6.02 p/Share
3,628 Reduced 54.74%
3,000 Common Stock
Jun 14 2022
BUY
Exercise of conversion of derivative security
$2,576 $0.71 p/Share
3,628 Added 35.37%
6,628 Common Stock
Jun 13 2022
SELL
Open market or private sale
$24,599 $6.01 p/Share
4,093 Reduced 57.7%
3,000 Common Stock
Jun 13 2022
BUY
Exercise of conversion of derivative security
$2,906 $0.71 p/Share
4,093 Added 36.59%
7,093 Common Stock
Jun 10 2022
SELL
Open market or private sale
$43,106 $6.05 p/Share
7,125 Reduced 70.37%
3,000 Common Stock
Jun 10 2022
BUY
Exercise of conversion of derivative security
$5,059 $0.71 p/Share
7,125 Added 41.3%
10,125 Common Stock
Jun 09 2022
SELL
Open market or private sale
$49,421 $6.49 p/Share
7,615 Reduced 71.74%
3,000 Common Stock
Jun 09 2022
BUY
Exercise of conversion of derivative security
$5,407 $0.71 p/Share
7,615 Added 41.77%
10,615 Common Stock
Jun 08 2022
SELL
Open market or private sale
$83,313 $6.63 p/Share
12,566 Reduced 80.73%
3,000 Common Stock
Jun 08 2022
BUY
Exercise of conversion of derivative security
$8,922 $0.71 p/Share
12,566 Added 44.67%
15,566 Common Stock
Jun 07 2022
SELL
Open market or private sale
$119,793 $6.61 p/Share
18,123 Reduced 85.8%
3,000 Common Stock
Jun 07 2022
BUY
Exercise of conversion of derivative security
$23,922 $1.32 p/Share
18,123 Added 47.35%
20,150 Common Stock
Jun 06 2022
SELL
Open market or private sale
$84,022 $6.03 p/Share
13,934 Reduced 82.28%
3,000 Common Stock
Jun 06 2022
BUY
Exercise of conversion of derivative security
$26,893 $1.93 p/Share
13,934 Added 45.14%
16,934 Common Stock
Jun 03 2022
SELL
Open market or private sale
$92,142 $6.05 p/Share
15,230 Reduced 83.54%
3,000 Common Stock
Jun 03 2022
BUY
Exercise of conversion of derivative security
$29,394 $1.93 p/Share
15,230 Added 45.52%
18,230 Common Stock
May 16 2022
SELL
Open market or private sale
$80,136 $7.42 p/Share
10,800 Reduced 78.26%
3,000 Common Stock
Jan 21 2022
BUY
Exercise of conversion of derivative security
$3,834 $0.71 p/Share
5,400 Added 30.4%
12,362 Common Stock
Dec 28 2021
BUY
Exercise of conversion of derivative security
$3,834 $0.71 p/Share
5,400 Added 43.68%
6,962 Common Stock
JRM

John R Moore

General Counsel
Boulder, CO

Track Institutional and Insider Activities on EWTX

Follow Edgewise Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

News

Receive news related to Edgewise Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EWTX